Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Qianhui Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; Department of Hepatobiliary Surgery and Liver Transplant…. Hauptthemen laut MEDLINE: Liver Neoplasms, Cholic Acid, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma remains a leading cause of cancer mortality worldwide, with peritumoral microenvironment interactions playing a critical role in disease progression. This multi-omics study employed artificial intelligence-pathology, single-nucleus multi-omics, spatial transcriptomics, and metabolomics to characterize peritumoral ductular reactions. Ductular reaction scores strongly predicted poor clinical outcomes and correlated with cirrhosis severity. We identified three functionally distinct cholangiocyte subpopulations, with Small_duct_type_Cho exhibiting robust fibroblast interactions that promote stromal remodeling. Metabolomic profiling revealed tumor margin enrichment of cholic acid, which induced CD8+ T cell dysfunction via NR1H4-dependent PD1 upregulation. Importantly, NR1H4 inhibition synergized with anti-PD1 therapy in murine models, significantly suppressing tumor growth. These results position ductular reactions as both a prognostic biomarker and therapeutic target, with cholic acid/NR1H4 pathway inhibition representing a promising immunotherapeutic strategy for hepatocellular carcinoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
- School of Computer Science and Technology, Xidian University, Xi'an, China.
- Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: gaoqiang@fudan.edu.cn.
- Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: docsong2013@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, Q., Chen, H., Wang, G., Wang, X., Shi, J., Cheng, Y., Xu, Y., Ma, S., Guo, S., Liu, X., Gao, Q., & Song, G. (2026). Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218393
Vancouver
Xu Q, Chen H, Wang G, Wang X, Shi J, Cheng Y, et al. Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218393
BibTeX
@article{Xu2026,
author = {Xu, Qianhui and Chen, Hang and Wang, Ganggang and Wang, Xiaodong and Shi, JieYi and Cheng, Yifei and Xu, Yanan and Ma, Sainan and Guo, Siqi and Liu, Xiyang and Gao, Qiang and Song, Guohe},
title = {Multi-omics profiling reveals cholic acid-mediated immunosuppression driven by peritumoral ductular reactions in hepatocellular carcinoma},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218393}
}
EUVIMED